The United States

George Clinical now has substantial operations in the USA, with 66 staff and leaders in oncology trials both operationally and scientifically.

George Clinical in The United States

George Clinical, leading Asia-Pacific CRO, expands into US with acquisition of a specialised oncology CRO Division

Headquartered in Sydney, Australia, George Clinical has offices in China, India, Hong Kong, South Korea, Taiwan, Malaysia, New Zealand, United Kingdom, Czech Republic and now the USA.

Over the years, George Clinical has grown rapidly across the Asia-Pacific region and is continuing to develop global operations. The combination of a strong commercial proficiency and clinical research and scientific excellence positions George Clinical as a high quality, global CRO with substantial clinical and scientific assets.

George Clinical now has substantial operations in the USA, with 42 staff and leaders in oncology trials both operationally and scientifically. We are here to support our US customers with their CRO needs and to lead oncology trials across our core operational facilities in the Asia Pacific region.

George Clinical US Staff Locations

George Clinical US News

George Clinical, leading Asia-Pacific CRO, expands into US with acquisition of a specialised oncology CRO Division

George Clinical, a leading full-service CRO in the Asia-Pacific region and Vector Oncology, a Memphis-based leader in oncology research and data analytics, formally announced today that George Clinical has acquired Vector Oncology’s Pharma Services (CRO) Division…

Diabetes raises risk of cancer, with women at even greater likelihood, a major new study has found

A global review involving almost 20 million people has shown that having diabetes significantly raises the risk of developing cancer, and for women the risk is even higher.

Potential breakthrough treatment for chronic kidney disease and diabetes

The CREDENCE trial, investigating a breakthrough treatment for chronic kidney disease and type 2 diabetes, has been ended early after benefit was demonstrated at an interim analysis.

New report to grow Australia and India partnerships a welcome step

The George Institute welcomes the report An India Economic Strategy to 2035: Navigating from potential to delivery authored by Mr Peter N Varghese AO for the Australian Government.

Novel app switches you to healthier options

Drop that yogurt. Instead, try this one with less sugar, fat and fewer unpronounceable additives.

Australia's supermarket shelves full of highly processed and highly unhealthy foods

Six out of ten Australian packaged foods are highly or ultra-processed, more than half are discretionary/junk foods and only one third are healthy, according to a new analysis by The George Institute for Global Health.

Yoga effective as a fall prevention strategy among the elderly, reveals new research

Falls are an emerging public health issue in India and a major cause of mortality and morbidity globally. It is estimated that 75 per cent of the fall injuries occur in low and middle-income countries and the impact set to rise as the population ages.

Details

Number of Personnel: 66
In-country Services: Business Development
Scientific Leadership
Oncology specialists
Project Management
Clinical Operations
Clinical Compliance
Regulatory Services
Medical and Safety management
Data Management
Statistics
Health Economics
Population: 321 million
Official Language: English 79.2%, Spanish 12.9%, other Indo-European 3.8%, Asian and Pacific island 3.3%, other 0.9%
Hospital Records Language: English

Twitter Facebook LinkedIn